DANA DE MOSS: Open Payments
NPI 1346241130 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,303 in 136 payments from 41 companies in 2025. Trend: 2023 $10,575 · 2024 $18,520 · 2025 $20,303
Speaker / faculty: $14,400Food & beverage: $3,567Travel & lodging: $2,280Education: $56
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $17,419 |
| Novartis Pharmaceuticals Corporation | 10 | $278 |
| Janssen Biotech, Inc. | 11 | $264 |
| Merck Sharp & Dohme LLC | 9 | $243 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $173 |
| JAZZ PHARMACEUTICALS INC. | 3 | $161 |
| GlaxoSmithKline, LLC. | 4 | $159 |
| Celgene Corporation | 6 | $145 |
| Regeneron Healthcare Solutions, Inc. | 7 | $144 |
| Daiichi Sankyo Inc. | 5 | $137 |
Products named: LYNPARZA, KEYTRUDA, LIBTAYO, Nubeqa, Enhertu, KISQALI, ZIIHERA, BREYANZI.
Industry payments across TN — which companies pay providers there.
